Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2010
02/11/2010US20100035908 Substituted acetophenones useful as pde4 inhibitors
02/11/2010US20100035891 Pharmaceutically Active Compounds
02/11/2010US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists
02/11/2010DE112008000841T5 Verbindung, photoelektrischer Wandler und photoelektrochemische Zelle Compound photoelectric transducer and photo-electrochemical cell
02/11/2010CA2738866A1 Flupirtine hydrochloride maleic acid cocrystal
02/11/2010CA2733105A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
02/11/2010CA2732932A1 Organic compounds
02/11/2010CA2732887A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
02/11/2010CA2732828A1 Novel phenylamino isonicotinamide compounds
02/11/2010CA2732765A1 Aminopyridine kinase inhibitors
02/11/2010CA2732682A1 Tripyridyl carboxamide orexin receptor antagonists
02/11/2010CA2732045A1 Urea derivatives as antibacterial agents
02/10/2010EP2151236A1 G-protein-conjugated receptor agonist
02/10/2010EP2150550A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
02/10/2010EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
02/10/2010EP2150531A2 Novel vanilloid receptor ligands, and their use for the production of pharmaceuticals
02/10/2010EP2150527A2 Anthranilic acid derivative as anticancer agent and a process for the preparation thereof
02/10/2010EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents
02/10/2010CN101646651A Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
02/10/2010CN101643447A Method for preparing 2-acetamido-5-aminopyridine
02/10/2010CN101643446A Method for preparing 2-amino-6-chloropyridine
02/10/2010CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof
02/09/2010US7659428 Methods for producing acylphenylalanine
02/09/2010US7659415 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers
02/09/2010US7659397 Pyrithione complex compound, process for producing the same and use thereof
02/09/2010US7659394 Substituted morpholine compounds for the treatment of central nervous system disorders
02/09/2010US7659307 Heterocyclic carboxamides and their use as fungicides
02/09/2010US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders
02/09/2010US7659270 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A)
02/09/2010US7659268 Modulators of ATP-binding cassette transporters
02/09/2010US7659228 Synergistic insecticide mixtures
02/09/2010CA2451962C Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
02/09/2010CA2451562C Piperazine compound
02/09/2010CA2451240C Cyclic diamine compound with 6 membered ring groups
02/09/2010CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
02/09/2010CA2430273C Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2406384C Synthesis of intermediates useful in preparing antihistamine tricyclic compounds
02/09/2010CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
02/09/2010CA2268403C Anthranilic acid derivatives as multi drug resistance modulators
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
02/04/2010WO2010014022A1 A process for the preparation of imatinib
02/04/2010WO2010013567A1 Amide derivative, pest control agent containing the amide derivative and pest controlling method
02/04/2010WO2010013242A1 Substituted pyridoxine-lactam carboxylate salts
02/04/2010WO2010013161A1 Fluorinated heteroaryls
02/04/2010WO2010013158A1 Phenanthrenone compounds, compositions and methods
02/04/2010WO2010012949A1 Marker reagents with a pyridine ring with a diazomethyl function substituent methods for synthesis of said reagents and methods for detecting biological molecules
02/04/2010WO2010012758A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
02/04/2010WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
02/04/2010US20100029952 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems
02/04/2010US20100029951 Process for producing acrylonitrile compound
02/04/2010US20100029950 Novel substituted 1h-dihydropyrazoles, their preparation and use
02/04/2010US20100029948 Process for the synthesis of diaminopyridines from glutaronitriles
02/04/2010US20100029947 Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them
02/04/2010US20100029689 Phosphodiesterase 4 inhibitors
02/04/2010US20100029647 3,4,(5)-substituted tetrahydrophyridines
02/04/2010US20100029588 Substituted phenylamidines and the use thereof as fungicides
02/04/2010US20100029578 Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds
02/04/2010DE102008035552A1 Substituierte Pyridine und ihre Verwendung Substituted pyridines and their use
02/04/2010CA2794350A1 Amide derivative, pest control agent containing the amide derivative, and pest controlling method
02/04/2010CA2737348A1 Amide derivative, pest control agent containing the amide derivative, and pest controlling method
02/04/2010CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
02/04/2010CA2730774A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
02/04/2010CA2729581A1 Fluorinated heteroaryls
02/04/2010CA2729578A1 Phenanthrenone compounds, compositions and methods
02/03/2010EP2149556A1 Method for manufacturing asymmetrical substituted dipyrazolyloxyphenyl derivatives
02/03/2010EP2148861A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
02/03/2010CN101641331A Process for the preparation of certain substituted sulfilimines
02/03/2010CN101638380A Compound, charge carrying material and organic electroluminescent element
02/03/2010CN100586944C 2,4,5,6-substituted pyrimidines, method for the production and use thereof for preventing epiphyte
02/03/2010CN100586933C No-catalyst hydrolysis method for preparing nicotinic acid from nicotinonitrile in near-critical water medium
02/03/2010CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/02/2010US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
02/02/2010US7655803 [1,3-Dimethylimidazolium][Me-(O CH2 CH2)2 O SO3]; Trioctylmethylammonium][Me-(O CH2 CH2)2 O SO3]; 1-Methylpyridinium][Me-(O CH2 CH2)5 O SO3]; treating the compound of formula (cation)(R O SO3) with an alcohol of the formula R' OH to form the desired ionic liquid and the by-product R OH
02/02/2010US7655749 contacting pyridines or pyrimidines monomer with a particlulate catalyst containing metal or alloy (e.g. magnesium or alloy substrate) having a second reduced metal or alloy ( Ni, Cu, Co etc.) coated on the substrate to form dimer ( bi-pyridine) or polymer
02/02/2010US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases
02/02/2010CA2442478C Use of group i mglur antagonists in the treatment of fragile x syndrome, autism, mental retardation
02/02/2010CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor
02/02/2010CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
02/02/2010CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
01/2010
01/28/2010WO2010011626A2 Pyridinyl modulators of ϒ-secretase
01/28/2010WO2010011584A2 Process for making a renin inhibitor
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010011435A1 Pyridyldiamido transition metal complexes, production and use thereof
01/28/2010WO2010011134A2 Ozonolysis of aromatics and/or olefins
01/28/2010WO2010010702A1 Prophylactic or therapeutic agent for axial myopia
01/28/2010WO2010010380A1 Potassium ion channel modulators & uses thereof
01/28/2010WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof
01/28/2010WO2010010017A1 Heterocyclic antiviral compounds
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers
01/28/2010WO2009124962A3 Sulfonamides
01/28/2010WO2008083054A3 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure
01/28/2010US20100022779 Isotopically substituted proton pump inhibitors
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022726 Pyridyldiamido Transition Metal Complexes, Production And Use Thereof